Oramed Pharmaceuticals (ORMP) Other financing activities (2019 - 2025)
Oramed Pharmaceuticals' (ORMP) quarterly Other financing activities came in at $500000.0 in Q1 2025, up 2400.0% on a QoQ basis from $20000.0 in Q4 2022.
Oramed Pharmaceuticals (ORMP) Other financing activities (2019 - 2025) Analysis & Trends
Oramed Pharmaceuticals (ORMP) has 4 years of Other financing activities data on file, last reported at $500000.0 in Q1 2025.
- Quarterly Other financing activities changed N/A year-over-year to $500000.0 in Q1 2025, while the trailing twelve-month figure through Sep 2025 was $520000.0 (changed N/A YoY) and the FY2022 annual result came in at $62000.0, changed N/A from the prior year.
- Other financing activities climbed to $500000.0 in Q1 2025, from $20000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $500000.0 in Q1 2025 to a low of $20000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.20 Bn | 131.35 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.09 Bn | 78.10 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.04 Bn | 9.65 Bn | 668.28 Mn |
| 8 | Insmed | 27.50 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.34 Bn | 26.50 Bn | - |
| 10 | Oramed Pharmaceuticals | 199.25 Mn | 199.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 500,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2022 | 20,000.00 |
| Dec 31, 2022 | 20,000.00 |
| Feb 29, 2020 | 1,000.00 |
| Feb 29, 2020 | 1,000.00 |
| Nov 30, 2019 | 12,000.00 |
| Nov 30, 2019 | 12,000.00 |